Nutrition
Volume 17, Issue 4 , Pages 315-321 , April 2001

Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk

  • Masao Kaneki, MD

      Affiliations

    • Department of Geriatric Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  • ,
  • Stephen J. Hedges, PhD

      Affiliations

    • Department of Human Metabolism and Clinical Biochemistry, Clinical Science Center, Northern General Hospital, University of Sheffield, Sheffield, UK
  • ,
  • Takayuki Hosoi, MD

      Affiliations

    • Department of Geriatric Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  • ,
  • Saeko Fujiwara, MD

      Affiliations

    • Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan
  • ,
  • Anthony Lyons, FRCSEd

      Affiliations

    • Department of Orthopaedic and Accident Surgery, University Hospital, Queen’s Medical Centre, Nottingham, UK
  • ,
  • St.John Crean, MBBS, FDSRCS

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Eastman Dental Institute, London, UK
  • ,
  • Nobuhiko Ishida, MD

      Affiliations

    • Umezono Hospital, Tokyo, Japan
  • ,
  • Mamoru Nakagawa, BA

      Affiliations

    • Sekisui Chemical Co., Ltd., Osaka, Japan
  • ,
  • Masahiro Takechi, BA

      Affiliations

    • Sekisui Chemical Co., Ltd., Osaka, Japan
  • ,
  • Yoshihisa Sano, PhD

      Affiliations

    • Drug Metabolism & Pharmacokinetcs, Eisai Co., Ltd., Ibaraki, Japan
  • ,
  • Yuzo Mizuno, MD

      Affiliations

    • Department of Geriatric Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  • ,
  • Shinjiro Hoshino, MD

      Affiliations

    • Department of Geriatric Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  • ,
  • Mariko Miyao, MD

      Affiliations

    • Department of Geriatric Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  • ,
  • Satoshi Inoue, MD

      Affiliations

    • Department of Geriatric Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  • ,
  • Kiyomi Horiki, MSc

      Affiliations

    • Department of Geriatric Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  • ,
  • Masataka Shiraki, MD

      Affiliations

    • Research Institute and Practice for Involutional Diseases, Nagano, Japan
  • ,
  • Yasuyoshi Ouchi, MD

      Affiliations

    • Department of Geriatric Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  • ,
  • Hajime Orimo, MD

      Affiliations

    • Department of Geriatric Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    • Corresponding Author InformationCorrespondence to: Takayuki Hosoi, MD, PhD, Endocrinology Section, Tokyo Metropolitan Geriatric Center, 35-2, Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan

,Accepted 16 October 2000.

References 

  1. Dam H. Antihaemorrhagic vitamin of the chic. Occurrence and chemical nature. Nature. 1935;135:652
  2. Suitte JW. Vitamin K. InL Diplock AK, ed. Fat-soluble vitamins. London: Heinemann, 1985:225
  3. Furie B, Furie BC. Review article (molecular basis of vitamin K-dependent g-carboxylation). Blood. 1990;75:1753
  4. Vermeer C. Review article (g-carboxyglutamate-containing proteins and vitamin K-dependent carboxylase). Biochem J. 1990;266:625
  5. Vermeer C, Hamulyaík K. Pathophysiology of vitamin K-deficiency and oral anticoagulants. Thromb Haemost. 1991;66:153
  6. Shearer MJ. Vitamin K metabolism and nutriture. Blood Rev. 1992;6:92
  7. Shearer MJ. The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Soc. 1997;56:915
  8. Rucker RB. Improved functional endpoints for use in vitamin K assessment (important implications for bone disease). Am J Clin Nutr. 1997;65:883
  9. Vermeer C, Knapen MH, Schurgers LJ. Vitamin K and metabolic bone disease. J Clin Pathol. 1998;51:424
  10. Price PA. Vitamin K-dependent formation of bone gla protein (osteocalcin) and its function. Vitam Horm. 1985;42:65
  11. Hauschka PV, Lian JB, Cole DE, et al.  Osteocalcin and matrix gla protein (vitamin K-dependent proteins in bone). Physiol Rev. 1989;68:990
  12. Maillard C, Berruryer M, Serre CM, et al.  Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology. 1992;130:1599
  13. Orimo H, Shiraki M, Fujita T, et al. Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis: a double-blind multicenter comparative study with 1ahydroxy vitamin D3. J Bone Miner Res 1992;7(suppl 1):S122
  14. Sato Y, Honda Y, Kuno H, et al.  Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone. 1998;23:291
  15. Iwamoto I, Kosha S, Noguchi S, et al.  A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women (a comparative study with vitamin D3 and estrogen-progestin therapy). Maturitas. 1999;31:161
  16. Craciun AM, Wolf J, Knapen MH, et al.  Improved bone metabolism in female elite athletes after vitamin K supplementation. Int J Sports Med. 1998;19:479
  17. Somekawa Y, Chigughi M, Harada M, et al.  Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide. J Clin Endocrinol Metab. 1999;84:2700
  18. Akiyama Y, Hara K, Ohkawa I, et al.  Effects of menatetrenone on bone loss induced by ovariectomy in rats. Jpn J Pharmacol. 1993;62:14
  19. Hara K, Akiyama Y, Ohkawa I, et al.  Effects of menatetrenone on prednisolone-induced bone loss in rats. Bone. 1993;14:913
  20. Tomiuga T, Kobayashi M, Nakajima Y, et al.  Effects of menatetrenone on the decrease in calcium balance induced by vitamin K-deficient diet and sodium loading in rats. Jpn J Pharmacol. 1994;65:35
  21. Ehara Y, Takahashi H, Hanahisa Y, et al.  Effect of vitamin K2 (menaquinone-7) on bone metabolism in the femoral-metaphyseal tissues of normal and skeletal-unloaded rats: enhancement with zinc. Res Exp Med (Berl). 1996;196:171
  22. Akiyama Y, Hara K, Kobayashi M, et al.  Inhibitory effect of vitamin K2 (menatetrenone) on bone resorption in ovariectomized rats (a histomorphometric and dual energy X-ray absorptiometric study). Jpn J Pharmacol. 1999;80:67
  23. Matsunaga S, Ito H, Sakou T. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int. 1999;65:285
  24. Yamaguchi M, Taguchi H, Gao YH, et al.  Effect of vitamin K2 (menaquinone-7) in fermented soybean (natto) on bone loss in ovariectomized rats. J Bone Miner Metab. 1999;17:23
  25. Philip WJ, Martin JC, Richardson JM, et al.  Decreased axial and peripheral bone density in patients taking long- term warfarin. QJM. 1995;88:635
  26. Lafforgue P, Daver L, Monties JR, et al.  Bone mineral density in patients given oral vitamin K antagonists. Rev Rhum Engl Ed. 1997;64:249
  27. Sato Y, Honda Y, Kunoh H, et al.  Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Stroke. 1997;28:2390
  28. Caraballo PJ, Heit JA, Atkinson EJ, et al.  Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med. 1999;159:1750
  29. Haffa A, Krueger D, Bruner J, et al.  Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats. J Bone Miner Res. 2000;15:872
  30. Jamal SA, Browner WS, Bauer DC, et al.  Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1998;128:829
  31. Rosen HN, Maitland LA, Suttie JW, et al.  Vitamin K and maintenance of skeletal integrity in adults. Am J Med. 1993;94:62
  32. Hart JP, Shearer MJ, Klenerman L, et al.  Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J Clin Endocrinol Metab. 1985;60:268
  33. Hodges SJ, Polkington MJ, Stamp TCB, et al.  Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone. 1991;12:387
  34. Hodges SJ, Akesson P, Vergnaud O, et al.  Circulating levels of vitamin K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res. 1993;8:1241
  35. Kaneki M, Mizuno Y, Hosoi T, et al.  Serum concentration of vitamin K in elderly women with involutional osteoporosis. Jpn J Geriatr. 1995;32:195
  36. Kanai T, Takagi T, Masuhiro K, et al.  Serum vitamin K level and bone mineral density in post-menopausal women. Int J Gynaecol Obstet. 1997;56:25
  37. Tamatani M, Morimoto S, Nakajima M, et al.  Decreased circulating levels of vitamin K and 25-hydroxyvitamin D in osteopenic elderly men. Metabolism. 1998;47:195
  38. Hara K, Akiyama Y, Tajima T, et al.  Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. J Bone Miner Res. 1993;8:535
  39. Kameda T, Miyazawa K, Mori Y, et al.  Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun. 1996;220:515
  40. Koshihara Y, Hoshi K, Ishibashi H, et al.  Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int. 1996;59:466
  41. Koshihara Y, Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res. 1997;12:431
  42. Szulc P, Arlot M, Chapuy MC, et al.  Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res. 1994;9:1591
  43. Jie KG, Bots ML, Vermeer C, et al.  Vitamin K status and bone mass in women with and without aortic atherosclerosis (a population-based study). Calcif Tissue Int. 1996;59:352
  44. Szulc P, Chapuy M-C, Meunier PJ, et al.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993;91:1769
  45. Kohlmeier M, Saupe J, Shearer MJ, et al.  Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int. 1997;51:1218
  46. Vergnaud P, Garnero P, Meunier PJ, et al.  Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women (the EPIDOS Study). J Clin Endocrinol Metab. 1997;82:719
  47. Knapen MH, Hamulyaík K, Veermeer C. The effects of vitamin K supplementation on circulating osteocalcin (bone gla protein) and urinary calcium excretion. Ann Intern Med. 1989;111:1001
  48. Kon-Siong GJ, Hamulyaík K, Birgit LM, et al.  Serum osteocalcin as a marker for vitamin status in pregnant women and their newborn babies. Thromb Haemost. 1991;65:52
  49. Douglas AS, Robins SP, Hutchison JD, et al.  Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone. 1995;17:15
  50. Feskanich D, Weber P, Willett WC, et al.  Vitamin K intake and hip fractures in women (a prospective study). Am J Clin Nutr. 1999;69:74
  51. Collins MD, Jones D. Distribution isoprenoid quinone structural types in bacteria and their taxonomic implications. Microbiol Rev. 1981;45:316
  52. Suttie JW. Vitamin K and human nutrition. J Am Diet Assoc. 1992;92:585
  53. Uchida K, Komeno T. Relationships between dietary and intestinal vitamin K, clotting factor levels, plasma vitamin K, and urinary gla. In: Suttie JW, ed. Current advances in vitamin K research. New York: Elsevier Science, 1988:477
  54. Shino M. Determination of endogenous vitamin K (phylloquinone and menaquinone-n) in plasma by high-performance liquid chromatography using platinum oxide catalyst reduction and fluorescence detection. Analyst. 1988;113:393
  55. Hodges SJ, Pilkington MJ, Shearer MJ, et al.  Age-related changes in the circulating levels of congeners of vitamin K2, menaquinone-7 and menaquinone-8. Clin Sci. 1990;78:63
  56. Plantalech L, Guillaumont M, Vergnaud P, et al.  Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. J Bone Miner Res. 1991;6:1211
  57. Hiraike H, Kimura M, Itokawa Y. Distribution of K vitamins (phylloquinone and menaquinones) in human placenta and maternal and umbilical cord plasma. Am J Obstet Gynecol. 1988;158:564
  58. Ohmoto Y. The study on the implication in pregnant women; hepaplastine test and plasma vitamin K concentration. Sanpu Chushi-Kaishi. 1991;39:162
  59. Sakano T, Notsumoto S, Nagaoka T, et al.  Measurement of K vitamins in food by high-performance liquid chromatography with fluorometric detection. Vitamins (Jpn). 1988;62:
  60. Ikeda H, Doi Y. A vitamin-K2-binding factor secreted from Bacillus subtilis. Eur J Biochem. 1990;192:219
  61. Orimo H, Hosoda Y, Fujiwara S, et al.  Fracture incidence in Japan. JBMM. 1991;9:89
  62. Orimo H, Hashimoto T, Shiraki M, et al.  Nation-wide survey of the hip fracture incidence in Japan. Jpn Med J. 1995;3707:27
  63. Landenberg JP, Tjaden UR. Improved method for the determination of vitamin K1 epoxide in human plasma with electrofluorimetric reaction detection. J Chromatogr. 1984;289:377
  64. Ikeda N, Saito Y, Shimizu J, et al.  Variations in concentrations of bacterial metabolites, enzyme activities, moisture, pH, and bacterial composition between and within individuals in faeces of seven healthy adults. J Appl Bacteriol. 1994;77:185
  65. The annual report on the family income and expenditure survey. Tokyo: Statistics Bureau, Management and Coordination Agency, 1987
  66. Saupe J, Shearer MJ, Kohlmeier M. Phylloquinone transport and its influence on g-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis. Am J Clin Nutr. 1993;58:204
  67. Fukutake M, Takahashi M, Ishida K, et al.  Quantification of genistein and genistin in soybeans and soybean products. Food Chem Toxicol. 1996;34:457
  68. Arjmandi BH, Getlinger MJ, Goyal NV, et al.  Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nut. 1998;68:1358S
  69. Hanawa Y, Maki M, Murata B, et al.  The second nationwide survey in Japan of vitamin K deficiency in infancy. Eur J Pediatr. 1988;147:472

PII: S0899-9007(00)00554-2

Nutrition
Volume 17, Issue 4 , Pages 315-321 , April 2001